Logo

Stephanie Bywater

May 08, 2018

Stephanie Bywater has been appointed chief compliance officer at NeoGenomics. Her appointment became effective May 1, and she replaces Steven Jones, who will remain an executive vice president and board member at the company. Jones and NeoGenomics reached an agreement in November 2016 where he would reduce his time commitment to the firm, effective May 1 2018.

Bywater has been compliance officer at NeoGenomics since May 2017 when she joined the firm. She was previously global compliance operations and Americas compliance officer at Varian Medical Systems. Before that, she was the compliance and prvacy officer for Myriad Genetics. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.